Teruflex Blood Anticoagulant Citrate Phosphate Dextrose Adenine (cpda-1) For Collection Of 450ml Of Blood Solution
Product Images NDC 53877-108

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Teruflex Blood Anticoagulant Citrate Phosphate Dextrose Adenine (cpda-1) For Collection Of 450ml Of Blood (NDC 53877-108). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Terumo Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig. 1, Fig. 2a, Fig. 2b (Teruflex 01)

An instructional diagram showing components and assembly of a blood anticoagulant device associated with TERUFLEX Blood Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1). It includes labeled parts such as a port cap, clamp, notch, diversion pouch, female luer port, CLIKTIP, and a male luer adapter, illustrating connection and use steps.*

FDA Label Image

Fig. 3a, Fig. 3b (Teruflex 02)

An instructional diagram showing two figures labeled 3a and 3b, illustrating the setup of a blood collection system. Fig. 3a depicts a container with a notch and tubing connected below. Fig. 3b shows the addition of a CLIKTIP 'Y' connector with a permanent seal and a blood collection tube attached at the bottom.*

FDA Label Image

Figure (Teruflex 03)

An instructional illustration showing the steps for sealing a rectangular container with tape. The first step depicts peeling the container's flap upward. The second step shows the flap folded over the container. The third step shows the flap sealed flat, secured with tape, labeled as 'Sealing with tape.'*

FDA Label Image

Figure (Teruflex 04)

An instructional illustration showing a close-up of a medical connector or adapter component, likely used in intravenous blood collection or anticoagulant administration systems. The image depicts a tube with an attached device featuring a sliding or locking mechanism and grip details.*

FDA Label Image

Figure (Teruflex 05)

An instructional illustration depicting a syringe attached to tubing secured with adhesive tape, likely demonstrating preparation or administration of the TERUFLEX Blood Anticoagulant CPDA-1 solution for intravenous use.*

FDA Label Image

Figure (Teruflex 06)

An instructional line drawing showing hands performing a blood collection procedure. One hand holds a blood collection needle connected to tubing, while the other hand secures the puncture site on the arm. An arrow indicates the direction to pull or operate the needle, demonstrating proper technique for intravenous blood draw.*

FDA Label Image

Figure (Teruflex 07)

A line drawing illustration showing a close-up of a person's fingers holding a device or component connected to a tubing line, likely related to blood collection or intravenous set-up. The image focuses on the hand interaction with a small inline component.*

FDA Label Image

Principal Display Panel (63 mL Bag Blister Pack Case Label)

Label for TERUFLEX Blood Bag System with Diversion Blood Sampling Arm containing Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1) solution for collection of 450 mL of blood. The label details components with specific amounts of citric acid, sodium citrate, sodium phosphate, dextrose, and adenine. Manufactured by Terumo Corporation, Tokyo, Japan, with a sterile, non-pyrogenic fluid path and NDC 53877-108-06.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.